期刊文献+

基因重排技术在皮肤淋巴增生性疾病中的应用

The application of gene rearrangement in cutaneous lymphoproliferative disorders(Review)
下载PDF
导出
摘要 目前关于皮肤淋巴瘤的分类标准主要有3种:REAL、EORTC和WHO。由于在分类和所用术语方面存在差异,引起了不小的争议和混乱。2005年美国Blood杂志正式发表了世界卫生组织(WHO)和欧洲癌症研究与治疗组织(EORTC)共同确定的皮肤淋巴瘤分类,正式名称为"WHO-EORTC"皮肤淋巴瘤分类,明确指出淋巴瘤确诊要依据临床表现、细胞形态学、免疫表型特征和受体基因重排方式。受体基因重排克隆性分析技术为解决这些问题提供了一条途径,成为辅助诊断的重要手段。 There are three kinds of classification of cutaneous lymphoma, including REAL, EORTC and WHO. The differences in the classification standards and terms between different groups have lead to controversy and confusion. The classification of cutaneous lymphomas have been published in Blood magazine in 2005. The formal name of "WHO-EORTC" cutaneous lymphoma elassification was deter- mined by WHO and the European Organization for research and treatment of cancer ( EORTC ), and the clinical manifestations, cell morphology, immunological phenotype and receptor gene rearrangement for the diagnosis of this disease were determined. The receptor gene rearrangement of clonality analysis technology would provide a way and become an important method for the diagnosis of cutaneous lymphoma.
出处 《皮肤病与性病》 2012年第4期208-210,共3页 Dermatology and Venereology
关键词 淋巴瘤 受体 基因 重排 Lymphoma Receptor Gene Rearrangement
  • 相关文献

参考文献24

  • 1许良中.恶性淋巴瘤病理学[M].上海:上海科学技术文献出版社,2002:280.
  • 2Safley AM, Buckley PJ, Creager AJ, et al. The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration [ J]. Arch Pathol Lab Med, 2004, 128 ( 12 ) : 1395 - 1403.
  • 3Langerak AW, Van Krieken JH, Wolvers-Tettero IL, et al. The role of molecular analysis of imnmnoglobulin and T cell receptor gene rear- rangement in the diagnosis of lymphoproliferative disorders [ J]. J Clin Pathol, 2001,54(7): 565-567.
  • 4钟梅,吕亚莉,赵坡,李向红.异源双链鉴定法检测淋巴瘤IgH、TCR-β基因重排[J].诊断病理学杂志,2004,11(4):255-256. 被引量:6
  • 5周爱萍,石远凯,冯奉仪,陆士新,何小慧,韩晓红.非霍奇金淋巴瘤自体外周血干细胞中肿瘤污染的临床研究[J].中华肿瘤杂志,2002,24(5):467-470. 被引量:10
  • 6Galimberti S, Brizzi F, Mameli M, et al. An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease de- tection [J]. LeuRes, 1999, 23(10):921-929.
  • 7Olsson K, Gerard CJ, Zehnder J, et al. Real-time t ( 11 ;14) and t (14;18) PCR assays provide sensitive and quantitative assessments of minimaL residual disease (MRD) [ J ]. Leukemia, 1999, 13 ( 11 ) : 1833-1842.
  • 8Catherwood MA, Alexander HD, MeManus DT, et al. Immunoglobu- lingene rearrangement investigations in the diagnosis of lymphoid ma- lignancies from formaldehyde-fixed biopsies [ J]. Leuk Lymphoma, 2003, 44(4) : 645-648.
  • 9Van Dongen JJ, Langerak AW, Bruggemantl M, et al. Design and standardization of PCR primers and protocols for detection of clonal imnmnoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED- 2 Concerted Action BMH4-CT98-3936 [J], Lukemia, 2003, 17( 12): 2257-2317.
  • 10Sandberg Y, Van Gastel-Mol EJ, Verbaaf B, et al. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonal- ity diagnostics [J]. J Mol Diagn, 2005, 7(4) : 495-503.

二级参考文献38

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部